FPGS and acute lymphoblastic leukemia: To explore the impact of FPGS gene mutations on MTX maintenance therapy, bioinformatics analysis was performed on a reported ALL patient (ALL028) who relapsed twice during MTX maintenance (at months 45 and 66).